Evidence map›Paper›PMID 33782387›Full record

ArticleTranslational psychiatry2021

Gradient of electro-convulsive therapy's antidepressant effects along the longitudinal hippocampal axis.

Lucien Gyger, Francesca Regen, Cristina Ramponi, Renaud Marquis, Jean-Frederic Mall, Kevin Swierkosz-Lenart, Armin von Gunten, Nicolas Toni, Ferath Kherif, Isabella Heuser and 1 more

Abstract read
In one paragraph

Article in Translational psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lucien GygerLREN, Dept. of clinical neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.ORCID 0000-0003-0349-2111
Francesca RegenDepartment of Psychiatry, Charité-Campus Benjamin Franklin, Berlin, Germany.
Cristina RamponiLREN, Dept. of clinical neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.ORCID 0000-0003-3762-6931
Renaud MarquisEEG and Epilepsy Unit, Department of Clinical Neuroscience, University Hospital of Geneva and Faculty of Medicine, Geneva, Switzerland.ORCID 0000-0002-1145-242X
Jean-Frederic MallOld Age Psychiatry service, Department of Psychiatry, Lausanne University Hospital (CHUV), and University of Lausanne, Lausanne, Switzerland.
Kevin Swierkosz-LenartOld Age Psychiatry service, Department of Psychiatry, Lausanne University Hospital (CHUV), and University of Lausanne, Lausanne, Switzerland.
Armin von GuntenOld Age Psychiatry service, Department of Psychiatry, Lausanne University Hospital (CHUV), and University of Lausanne, Lausanne, Switzerland.
Nicolas ToniCentre for Psychiatric Neurosciences, Department of Psychiatry, Lausanne University Hospital (CHUV) and Lausanne University, Lausanne, Switzerland.ORCID 0000-0001-5585-268X
Ferath KherifLREN, Dept. of clinical neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.ORCID 0000-0001-5698-0413
Isabella HeuserDepartment of Psychiatry, Charité-Campus Benjamin Franklin, Berlin, Germany.
Bogdan DraganskiLREN, Dept. of clinical neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland. bogdan.draganski@chuv.ch.ORCID 0000-0002-5159-5919

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 32003B_159780Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 324730_192755
6 · The paper itself

Abstract

Despite decades of successful treatment of therapy-resistant depression and major scientific advances in the field, our knowledge about electro-convulsive therapy's (ECT) mechanisms of action is still scarce. Building on strong empirical evidence for ECT-induced hippocampus anatomy changes, we sought to test the hypothesis that ECT has a differential impact along the hippocampus longitudinal axis. We acquired behavioural and brain anatomy magnetic resonance imaging (MRI) data in patients with depressive episode undergoing ECT (n = 9) or pharmacotherapy (n = 24) and healthy controls (n = 30) at two time points 3 months apart. Using whole-brain voxel-based statistical parametric mapping and topographic analysis focused on the hippocampus, we observed ECT-induced gradient of grey matter volume increase along the hippocampal longitudinal axis with predominant impact on its anterior portion. Clinical outcome measures showed strong correlations with both baseline volume and rate of ECT-induced change exclusively for the anterior, but not posterior hippocampus. We interpret our findings confined to the anterior hippocampus and amygdala as additional evidence of the regional specific impact of ECT that unfolds its beneficial effect on depression via the "limbic" system. Main limitations of the study are patients' polypharmacy, heterogeneity of psychiatric diagnosis, and long-time interval between scans.

Indexed as

Depressive Disorder, Treatment-ResistantElectroconvulsive TherapyAntidepressive AgentsGray MatterHippocampusHumansMagnetic Resonance ImagingAntidepressive Agents

Identifiers

PMID33782387
PMCPMC8007583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.